Chinese scientists on 26 October 2013 announced the independently
developed a vaccine for the H7N9 bird flu virus.
The
vaccine was jointly developed by the School of Medicine of the Zhejiang
University, Hong Kong University, Chinese Center for Disease Control and
Prevention, National Institute for Food and Drug Control, and the Chinese
Academy of Medical Sciences.
China
reported the world's first human case for H7N9 bird flu infection in March
2013. As of now, a total of 136 people were confirmed to have been infected
with the virus. Of the infected, 45 died, representing a fatality rate of about
33 per cent.
Avian influenza A H7 viruses are a group of influenza viruses that
normally circulate among birds. The avian influenza A (H7N9) virus is one
subgroup among the larger group of H7 viruses. Although some H7 viruses (H7N2,
H7N3 and H7N7) have occasionally been found to infect humans.
No comments:
Post a Comment